BioSpace News Archive

Business

Probiodrug Reports Management Changes

Probiodrug AG announced today that effective October 31, 2018, and with the contractual termination of her current agreement, Dr. Inge Lues’ term as Chief Development Officer will come to an end.

October 9, 2018
·
5 min read
INTEGRA celebrates success with the ASSIST PLUS at MipTec 2018

The ASSIST PLUS pipetting robot from INTEGRA Biosciences received a prestigious Basel Life MipTec Product Innovation Award 2018 at this year’s MipTec exhibition.

October 9, 2018
·
2 min read
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism

Fast-emerging area of research with potential to treat severe diseases including cancer and autoimmune conditions

October 9, 2018
·
5 min read
Genetown

MilliporeSigma’s Novel Chemiflex™ Raw Materials Program Solves Regulatory Compliance Challenges in Small Molecule Drug Manufacturing

Bridges the raw material qualification gap, simplifying scale-up to cGMP manufacturing of active pharmaceutical ingredients

October 9, 2018
·
1 min read
Business

eTheRNA opens state-of-the-art manufacturing facility in Belgium to support the development of its TriMix-based mRNA cancer immunotherapies

eTheRNA immunotherapies announces the opening of a state-of-the-art mRNA manufacturing facility enabling the production of mRNA immunotherapies.

October 9, 2018
·
4 min read
Policy

TFS Collaboration with Lobsor Pharmaceuticals AB, on the Development of Lecigon®, Has Resulted in Marketing Authorization of Lecigon® in Sweden

TFS International is thrilled with the announcement that Lecigon®, a new therapeutic system for symptomatic treatment of Advanced Parkinson’s Disease (APD), has been granted marketing authorization in Sweden.

October 9, 2018
·
2 min read
Deals

Gene Therapy Company MeiraGTx Buys Vector Neurosciences for Its Phase II Parkinson’s Product

MeiraGTx, headquartered in London, UK, acquired Vector Neurosciences in an all-stock deal. As part of the deal, MeiraGTx picks up Vector’s Phase II gene therapy program for Parkinson’s disease.

October 9, 2018
·
2 min read
·
Mark Terry
Business

Merck’s Frazier Joins Growing List of Pharma CEOs Attacking Drug Rebates

Kenneth Frazier, chief executive officer of Merck, speaking with the Economic Club of New York, joined a growing list of pharmaceutical chiefs in criticizing the role of middlemen in rising drug prices.

October 9, 2018
·
3 min read
·
Mark Terry
Drug Development

Landmark Study: Researchers Cure Lethal Disease in Prenatal Mice Using CRISPR

CRISPR, the gene editing technique that scientists claim will lead to the cure and prevention of countless diseases and disorders, took a big step in that direction. Researchers at Children’s Hospital of Philadelphia (CHOP) used CRISPR to prevent a deadly metabolic disorder in prenatal laboratory animals.

October 9, 2018
·
3 min read
·
Mark Terry
Solentim Wins Two Queen’s Awards for Enterprise

Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation

October 9, 2018
·
2 min read